In addition to promoting tumor growth via formation of vasculature, VEGF-A has also been shown to promote an immunosuppressive TME via upregulation of Tregs, promotion of M2 TAM [68], and enhancement CTLA-4 and PD-1 signaling for suppression of CD8+ T cells in murine models [69]. The gene discussed is CTLA4; the disease is neoplasm.